EPSTEIN BARR VIRUS NUCLEAR ANTIGEN POSITIVE LYMPHOMA AFTER CYCLOSPORIN A TREATMENT IN PATIENT WITH RENAL ALLOGRAFT

[1]  J. Nagington,et al.  CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMA , 1980, The Lancet.

[2]  C. Y. Wang,et al.  Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers. , 1980, Blood.

[3]  B. Reitz,et al.  MALIGNANT LYMPHOMA IN CYCLOSPORIN A TREATED ALLOGRAFT RECIPIENTS , 1980, The Lancet.

[4]  R. Doll,et al.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. , 1979, British medical journal.

[5]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.

[6]  R. Levy,et al.  Immunopathology of follicular lymphomas. A model of B-lymphocyte homing. , 1978, The New England journal of medicine.

[7]  Y. Latour,et al.  Effects of sotalol in twenty patients with cardiac arrhythmias. , 1977, International journal of clinical pharmacology and biopharmacy.

[8]  P. H. Morgan,et al.  Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II. , 1976, Journal of pharmaceutical sciences.

[9]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[10]  Singh Bn.  Anti-arrhythmic actions of -adrenergic receptor antagonists: review of fundamental aspects. , 1972 .

[11]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[12]  Williams,et al.  Classification of antiarrhythmic drugs , 1975 .